In addition, drugs that promote read-through of pre-termination codons associated with BMPR2 mutation that result in non-sense mediated decay of the mutant mRNA product, also increase expression of functional BMPR2 mutant products in cells from patients with HPAH [16,17]. This evidence concerns the gene BMPR2 and heritable pulmonary arterial hypertension.